Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Log out
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

For authors

About

Browse by collection
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Agence Bibliographique de l Enseignement Superieur (ABES)

Oncology

How accurate is clinical prognostication by oncologists during routine practice in a general hospital and can it be improved by a specific prognosis training programme: a prospective interventional study
Irma Kupf, Gabriele Thanner, Michael Gerken, Alexander Crispin, Jan Braess

BMJ Open Jun 2024, 14 (6) e081661; DOI: 10.1136/bmjopen-2023-081661
Examining the role of resilience in the relationship between social support and fear of recurrence among patients with gastric cancer on chemotherapy: a cross-sectional study in Jiangsu, China
Lihua Yang, Yi Li, Xiaoqing Wang, Chao Xia, Liping Yang, Xun Li, Yanling Zou, Qiong Wang, Qingmei Hou, Peibei Duan, Ziyan Zhang

BMJ Open Jun 2024, 14 (6) e078679; DOI: 10.1136/bmjopen-2023-078679
Efficacy and safety of SBRT combined with sintilimab and IBI305 in patients with advanced HCC and previously failed immunotherapy: study protocol of a phase 2 clinical trial
Jinfeng Zhang, Yongqiang Yang, Zilong Wu, Sisi Zhang, Zhenyu Lin, Hongli Liu, Jianli Hu, Tao Zhang, Jing Tang, Jun Xue

BMJ Open Jun 2024, 14 (6) e077903; DOI: 10.1136/bmjopen-2023-077903
Application of the ESMO Magnitude of Clinical Benefit Scale to assess the clinical benefit of antibody drug conjugates in solid cancer: a systematic descriptive analysis of phase III and pivotal phase II trials
Lieming Ding, Xiaobin Yuan, Yang Wang, Zhilin Shen, Pengxiang Wu

BMJ Open Jun 2024, 14 (6) e077108; DOI: 10.1136/bmjopen-2023-077108
Non-pharmaceutical interventions for depressive symptoms in patients with breast cancer: protocol for a systematic review and network meta-analysis
Ping Yin, Lumin Liu, Ningyang Gao, Yisheng Huai, Yiyue Dong, Qi Jin, Yue-lai Chen

BMJ Open Jun 2024, 14 (6) e081281; DOI: 10.1136/bmjopen-2023-081281
Donafenib as neoadjuvant therapy in locally advanced thyroid cancer: protocol for the DONATHYCA phase II prospective single-arm trial in China
Jianhong Yu, Hui Liu, Yu Wu

BMJ Open May 2024, 14 (5) e081090; DOI: 10.1136/bmjopen-2023-081090
18F-FDG PET/MR for diagnosis of primary central nervous system lymphoma: protocol for a systematic review and meta-analysis
Xiaowei Qiu, Hong Zheng, Fangming Zhong, Bin Shen

BMJ Open May 2024, 14 (5) e081458; DOI: 10.1136/bmjopen-2023-081458
Effectiveness of educational and psychological survivorship interventions to improve health-related quality of life outcomes for men with prostate cancer on androgen deprivation therapy: a systematic review
Sally AM Sara, Nicole Heneka, Anna Green, Suzanne K Chambers, Jeff Dunn, Victoria R Terry

BMJ Open May 2024, 14 (5) e080310; DOI: 10.1136/bmjopen-2023-080310
Breaking bad news in oncology practice: experience and challenges of oncology health professionals in Ethiopia – an exploratory qualitative study
Tefera Mulugeta, Wudma Alemu, Wondemagegnehu Tigeneh, Mirgissa Kaba, Werissaw Haileselassie

BMJ Open May 2024, 14 (5) e087977; DOI: 10.1136/bmjopen-2024-087977
Modular multimodal hospital-home chain physical activity rehabilitation programme (3M2H-PARP) in liver cancer: a protocol for a randomised controlled trial
Haiyan Chen, Hanxiao Lu, Huimin Zhou, Bo Wu, Zhixia Dong, Shuo Zhang, Yuanlong Gu, Guangwen Zhou, Jie Xiang, Jun Yang

BMJ Open May 2024, 14 (5) e083228; DOI: 10.1136/bmjopen-2023-083228

Pages